These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37989289)

  • 1. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
    Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
    Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE).
    Kodama S; Arai N; Hagiwara A; Kimura A; Takeuchi S
    J Intensive Care; 2018; 6():43. PubMed ID: 30083346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptogenic new-onset refractory status epilepticus (NORSE) following blood transfusion in a patient with severe anemia.
    Wu CK; Culbertson CJ; Von Stein EL; Walia S; Krishnamohan P; Threlkeld ZD
    Epileptic Disord; 2021 Apr; 23(2):403-406. PubMed ID: 33881399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies.
    Lattanzi S; Leitinger M; Rocchi C; Salvemini S; Matricardi S; Brigo F; Meletti S; Trinka E
    Eur J Neurol; 2022 Feb; 29(2):626-647. PubMed ID: 34661330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New onset refractory status epilepticus: State of the art.
    Périn B; Szurhaj W
    Rev Neurol (Paris); 2022; 178(1-2):74-83. PubMed ID: 35031143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
    Carson R; Stredny CM
    Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute encephalitis with refractory partial status epilepticus treated with early immunotherapies including plasma exchange: a case report].
    Yamamoto D; Uchiyama T; Bunai T; Sato K; Shimizu T; Tanaka K; Ohashi T
    Rinsho Shinkeigaku; 2014; 54(9):715-20. PubMed ID: 25283825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New onset refractory status epilepticus (NORSE).
    Sculier C; Gaspard N
    Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
    Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
    Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
    Sheikh Z; Hirsch LJ
    Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: A systematic review and meta-analysis.
    Tharmaraja T; Ho JSY; Neligan A; Rajakulendran S
    Epilepsia; 2023 May; 64(5):1113-1124. PubMed ID: 36727541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
    J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
    Khawaja AM; DeWolfe JL; Miller DW; Szaflarski JP
    Epilepsy Behav; 2015 Jun; 47():17-23. PubMed ID: 26010959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Torres AR
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.
    Gall CR; Jumma O; Mohanraj R
    Seizure; 2013 Apr; 22(3):217-20. PubMed ID: 23333762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
    Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
    Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
    Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A
    Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible splenial lesion in a patient with new-onset refractory status epilepticus (NORSE).
    Mizutani AU; Shindo A; Arikawa S; Shimada T; Matsuura K; Ikejiri K; Suzuki K; Imai H; Tomimoto H
    eNeurologicalSci; 2020 Mar; 18():100220. PubMed ID: 31909228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment.
    Wadayama T; Shimizu M; Yata T; Ishikura T; Kajiyama Y; Hirozawa D; Okuno T; Mochizuki H
    J Neuroimmunol; 2022 Feb; 363():577789. PubMed ID: 34973472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.